NCT03582332View on ClinicalTrials.gov

Serum Creatinine Change / Renal Adverse Effect With Use of Non-steroidal Painkillers in Axial Spondyloarthritis Patients

PHASE4CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 2, 2016

Primary Completion Date

June 23, 2016

Study Completion Date

June 23, 2016

Conditions

Axial Spondyloarthritis

Interventions

DRUG

Indomethacin SR, 75 Mg Oral Capsule, Extended Release

Indomethacin SR, 75 Mg Oral Capsule, Extended Release orally twice daily

DRUG

Indomethacin 25 Mg Oral Capsule

Indomethacin 25 Mg Oral Capsule, 2 capsule orally twice daily

DRUG

Etoricoxib 90 mg

Etoricoxib 90 mg once daily orally

DRUG

Etoricoxib 60 mg

Etoricoxib 60 mg once daily orally

All Listed Sponsors

lead

Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh

OTHER

NCT03582332 - Serum Creatinine Change / Renal Adverse Effect With Use of Non-steroidal Painkillers in Axial Spondyloarthritis Patients | Biotech Hunter | Biotech Hunter